Therapeutic and Diagnostic Challenges in Myasthenia Gravis

Link to article at PubMed

Neurol Clin. 2020 Aug;38(3):577-590. doi: 10.1016/j.ncl.2020.03.005. Epub 2020 Jun 11.


"Myasthenia gravis (MG) is the most common autoimmune neuromuscular disorder. This article highlights several cases that the practicing neurologist may encounter in the treatment of MG. Diagnostic uncertainty continues to be an issue in patients who are seronegative to the 2 most common antibodies, acetylcholine receptor and muscle-specific tyrosine kinase (MuSK). Specific populations of patients with MG including MuSK MG, thymomatous MG, refractory MG, and pregnant women also require special consideration. This article reviews specific cases and an update on current management."

PMID:32703470 | DOI:10.1016/j.ncl.2020.03.005

Leave a Reply

Your email address will not be published. Required fields are marked *